Mint3‐targeted therapy: A novel therapeutic strategy for urothelial carcinoma
Main Authors: | Fuda Xie, Bonan Chen, Alvin H.K. Cheung, Jun Yu, Ka Fai To, Wei Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.172 |
Similar Items
-
Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma
by: Junichi Ikeda, et al.
Published: (2023-02-01) -
Enhanced oxidative stress and the glycolytic switch in superficial urothelial carcinoma of urinary bladder
by: Yu-Wei Lai, et al.
Published: (2016-12-01) -
Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
by: Deng Lin, et al.
Published: (2022-12-01) -
Urothelial carcinoma arising within bladder diverticulum—Report of a case and review of the literature
by: Hung-En Chen, et al.
Published: (2016-09-01) -
Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma
by: Kyotaro Fukuta, et al.
Published: (2022-03-01)